Found: 2
Select item for more details and to access through your institution.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
- By:
- Publication type:
- Article
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 21, p. 3880, doi. 10.1002/cncr.34459
- By:
- Publication type:
- Article